BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29414417)

  • 1. Generation of novel induced pluripotent stem cell (iPSC) line from a 16-year-old sialidosis patient with NEU-1 gene mutation.
    Liu SP; Hsu YH; Huang CY; Ho MC; Cheng YC; Wen CH; Lu HE; Tsai CH; Shyu WC; Hsieh PCH
    Stem Cell Res; 2018 Apr; 28():39-43. PubMed ID: 29414417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathology of NEU1 gene in sialidosis.
    Seyrantepe V; Poupetova H; Froissart R; Zabot MT; Maire I; Pshezhetsky AV
    Hum Mutat; 2003 Nov; 22(5):343-52. PubMed ID: 14517945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of human induced pluripotent stem cells (hIPSCs) from sialidosis types I and II patients with pathogenic neuraminidase 1 mutations.
    Han MJ; Annunziata I; Weesner J; Campos Y; Salie M; O'Reilly C; d'Azzo A
    Stem Cell Res; 2020 Jul; 46():101836. PubMed ID: 32485644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Sialidosis with Neural Precursor Cells Derived from Patient-Derived Induced Pluripotent Stem Cells.
    Seol B; Kim YD; Cho YS
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splice donor site mutation in the lysosomal neuraminidase gene causing exon skipping and complete loss of enzyme activity in a sialidosis patient.
    Penzel R; Uhl J; Kopitz J; Beck M; Otto HF; Cantz M
    FEBS Lett; 2001 Jul; 501(2-3):135-8. PubMed ID: 11470272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and electrophysiological characteristics of a type 1 sialidosis patient with a novel deletion mutation in NEU1 gene.
    Fan SP; Lee NC; Lin CH
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 3):406-412. PubMed ID: 31371146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a human induced pluripotent stem cell (iPSC) line from a 51-year-old female with attention-deficit/hyperactivity disorder (ADHD) carrying a duplication of SLC2A3.
    Jansch C; Günther K; Waider J; Ziegler GC; Forero A; Kollert S; Svirin E; Pühringer D; Kwok CK; Ullmann R; Maierhofer A; Flunkert J; Haaf T; Edenhofer F; Lesch KP
    Stem Cell Res; 2018 Apr; 28():136-140. PubMed ID: 29477591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutations in the neuraminidase-1 (NEU1) gene in two patients of sialidosis in India.
    Ranganath P; Sharma V; Danda S; Nandineni MR; Dalal AB
    Indian J Med Res; 2012 Dec; 136(6):1048-50. PubMed ID: 23391804
    [No Abstract]   [Full Text] [Related]  

  • 9. Type 1 Sialidosis Patient With a Novel Deletion Mutation in the NEU1 Gene: Case Report and Literature Review.
    Ahn JH; Kim AR; Lee C; Kim NKD; Kim NS; Park WY; Kim M; Youn J; Cho JW; Kim JS
    Cerebellum; 2019 Jun; 18(3):659-664. PubMed ID: 30635863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and molecular characterization of novel mutations in GLB1 and NEU1 in patient cells with lysosomal storage disorders.
    Kwak JE; Son MY; Son YS; Son MJ; Cho YS
    Biochem Biophys Res Commun; 2015 Feb; 457(4):554-60. PubMed ID: 25600812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a transgene-free induced pluripotent stem cells line (UNIPDi002-A) from oral mucosa epithelial stem cells carrying the R304Q mutation in TP63 gene.
    Trevisan M; Barbaro V; Riccetti S; Masi G; Barzon L; Nespeca P; Alvisi G; Di Iorio E; Palù G
    Stem Cell Res; 2018 Apr; 28():149-152. PubMed ID: 29486400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex.
    Lukong KE; Elsliger MA; Chang Y; Richard C; Thomas G; Carey W; Tylki-Szymanska A; Czartoryska B; Buchholz T; Criado GR; Palmeri S; Pshezhetsky AV
    Hum Mol Genet; 2000 Apr; 9(7):1075-85. PubMed ID: 10767332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus-mediated expression.
    Pattison S; Pankarican M; Rupar CA; Graham FL; Igdoura SA
    Hum Mutat; 2004 Jan; 23(1):32-9. PubMed ID: 14695530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialidosis type I presenting with a novel mutation and advanced neuroimaging features.
    Gultekin M; Bayramov R; Karaca C; Acer N
    Neurosciences (Riyadh); 2018 Jan; 23(1):57-61. PubMed ID: 29455223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical variability of type II sialidosis by C808T mutation.
    Rodríguez Criado G; Pshezhetsky AV; Rodríguez Becerra A; Gómez de Terreros I
    Am J Med Genet A; 2003 Feb; 116A(4):368-71. PubMed ID: 12522793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of abnormal sialylglycoproteins in fibroblasts with sialidosis and galactosialidosis by normal gene transfer and enzyme replacement.
    Oheda Y; Kotani M; Murata M; Sakuraba H; Kadota Y; Tatano Y; Kuwahara J; Itoh K
    Glycobiology; 2006 Apr; 16(4):271-80. PubMed ID: 16361247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialidosis presenting as severe nonimmune fetal hydrops is associated with two novel mutations in lysosomal alpha-neuraminidase.
    Loren DJ; Campos Y; d'Azzo A; Wyble L; Grange DK; Gilbert-Barness E; White FV; Hamvas A
    J Perinatol; 2005 Jul; 25(7):491-4. PubMed ID: 15908988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene.
    Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
    Stem Cell Res; 2019 Jan; 34():101381. PubMed ID: 30677723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of an induced pluripotent stem cell (iPSC) line from a 40-year-old patient with the A8344G mutation of mitochondrial DNA and MERRF (myoclonic epilepsy with ragged red fibers) syndrome.
    Wu YT; Hsu YH; Huang CY; Ho MC; Cheng YC; Wen CH; Ko HW; Lu HE; Chen YC; Tsai CL; Hsu YC; Wei YH; Hsieh PCH
    Stem Cell Res; 2018 Mar; 27():10-14. PubMed ID: 29288969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant.
    Cheng YC; Huang CY; Ho MC; Hsu YH; Syu SH; Lu HE; Lin HI; Lin CH; Hsieh PCH
    Stem Cell Res; 2018 Apr; 28():1-5. PubMed ID: 29414410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.